Aren't they actually an investment firm with a passing interest in software?
Maybe you should actually read one of their earnings reports. They don’t make $250B in annual revenue because of a “passing interest in software”.
They're like the Merck of the pharma world.
Fair point
Maybe you should actually read one of their earnings reports. They don’t make $250B in annual revenue because of a “passing interest in software”.